(Q37002423)

17 August 2017

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay (English)

1 reference

primary biliary cholangitis

17 August 2017

0 references

0 references

author

Adrian M. Di Bisceglie

16

object named as

Adrian Di Bisceglie

1 reference

17 August 2017

3

Beverley Adams-Huet

1 reference

17 August 2017

Marlyn J Mayo

1

1 reference

17 August 2017

Julie Parkes

2

1 reference

17 August 2017

Burton Combes

4

1 reference

17 August 2017

A S Mills

5

1 reference

17 August 2017

Rodney S Markin

6

1 reference

17 August 2017

Raphael Rubin

7

1 reference

17 August 2017

Donald Wheeler

8

1 reference

17 August 2017

Melissa Contos

9

1 reference

17 August 2017

A B West

10

1 reference

17 August 2017

Sandra Saldana

11

1 reference

17 August 2017

Yonas Getachew

12

1 reference

17 August 2017

Robert Butsch

13

1 reference

17 August 2017

Velimir Luketic

14

1 reference

17 August 2017

Marion Peters

15

1 reference

17 August 2017

Nathan Bass

17

1 reference

17 August 2017

John Lake

18

1 reference

17 August 2017

Thomas Boyer

19

1 reference

17 August 2017

Enrique Martinez

20

1 reference

17 August 2017

James Boyer

21

1 reference

17 August 2017

Guadalupe Garcia-Tsao

22

1 reference

17 August 2017

David Barnes

23

1 reference

17 August 2017

William M Rosenberg

24

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

17 August 2017

1 reference

17 August 2017

48

1 reference

17 August 2017

5

1 reference

17 August 2017

1549-1557

1 reference

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Accuracy of staging in primary biliary cirrhosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Histological grading and staging of chronic hepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Nonsuppurative destructive chronic cholangitis and chronic hepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

29 September 2017

1 reference

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

21 January 2018

1 reference

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

21 January 2018

1 reference

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

21 January 2018

When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

4 September 2018

1 reference

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

21 January 2018

1 reference

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

21 January 2018

1 reference

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

21 January 2018

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Liver biopsy size matters in chronic hepatitis: bigger is better

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597274

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index

4 September 2018

1 reference

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18846542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Primary biliary cirrhosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18846542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18846542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.22517

1 reference

17 August 2017

1 reference

17 August 2017

1 reference